Literature DB >> 15933932

Update on the paris classification of superficial neoplastic lesions in the digestive tract.

.   

Abstract

BACKGROUND AND STUDY AIMS: Neoplastic lesions in the digestive-tract mucosa are termed "superficial" when the depth of invasion is limited to the mucosa and submucosa. The endoscopic appearance has a predictive value for invasion into the submucosa, which is critical for the risk of nodal metastases.
MATERIALS AND METHODS: The endoscopic morphology of superficial lesions can be assessed with a standard video endoscope after spraying of a dye--an iodine-potassium iodide solution for the stratified squamous epithelium, or an indigo carmine solution for the columnar epithelium. In 2002, a workshop was held in Paris to explore the relevance of the Japanese classification. The conclusions were revised in 2003 in Osaka in relation to the definition of the subtypes used in endoscopy and the evaluation of the depth of invasion into the submucosa. In Japan, the description of advanced cancer in the digestive-tract mucosa using types 1 - 4 is supplemented by a type 0 when the endoscopic appearance is that of a superficial lesion. Type 0 is divided into three categories: protruding (0 - I), nonprotruding and nonexcavated (0 - II), and excavated (0 - III). Type 0 - II lesions are then subdivided into slightly elevated (IIa), flat (IIb), or depressed (IIc). Nonprotruding depressed lesions are associated with a higher risk of submucosal invasion. After endoscopic resection, invasion into the submucosa is an important criterion for the necessity of additional surgical resection. Micrometer analysis of the depth of invasion in the specimen is more precise, and distinct cut-off limits have been established in the esophagus, stomach, and large bowel.
CONCLUSIONS: The morphology of superficial and nonprotruding neoplastic lesions is relevant to the prognosis. Following endoscopic detection, the lesions are analyzed using chromoendoscopy and assigned a subtype of the type 0 classification. The choice between endoscopic or surgical treatment is based on this description.

Entities:  

Mesh:

Year:  2005        PMID: 15933932     DOI: 10.1055/s-2005-861352

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  200 in total

Review 1.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

2.  Endoscopic mucosal resection: who and how?

Authors:  Jayan Mannath; Krish Ragunath
Journal:  Therap Adv Gastroenterol       Date:  2011-09       Impact factor: 4.409

Review 3.  Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?

Authors:  Vani J A Konda; Mark K Ferguson
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

4.  Stretching Causes Extensive Changes of Gastric Submucosa: Is It Acceptable to Define 500 microm as the Safe Margin?

Authors:  Sanghoon Park; Hoon Jai Chun; Yong Dae Kwon; Bora Keum; Yeon Seok Seo; Yong Sik Kim; Yoon-Tae Jeen; Soon Ho Um; Chang Duck Kim; Ho Sang Ryu; Ji Hye Lee; Yang-Seok Chae
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

5.  Endoscopic mucosal resection and endoscopic submucosal dissection as treatments for early gastrointestinal cancers in Western countries.

Authors:  Sergio Coda; Sun-Young Lee; Takuji Gotoda
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

6.  Endoscopic resection techniques and ablative therapies for Barrett's neoplasia.

Authors:  Jacobo Ortiz-Fernández-Sordo; Adolfo Parra-Blanco; Alejandro García-Varona; María Rodríguez-Peláez; Erika Madrigal-Hoyos; Irving Waxman; Luis Rodrigo
Journal:  World J Gastrointest Endosc       Date:  2011-09-16

7.  In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video).

Authors:  Marcia Irene Canto; Sharmila Anandasabapathy; William Brugge; Gary W Falk; Kerry B Dunbar; Zhe Zhang; Kevin Woods; Jose Antonio Almario; Ursula Schell; John Goldblum; Anirban Maitra; Elizabeth Montgomery; Ralf Kiesslich
Journal:  Gastrointest Endosc       Date:  2013-11-09       Impact factor: 9.427

8.  Efficacy Evaluation of SAVE for the Diagnosis of Superficial Neoplastic Lesion.

Authors:  Farah Deeba; Shahed K Mohammed; Francis Minhthang Bui; Khan A Wahid
Journal:  IEEE J Transl Eng Health Med       Date:  2017-05-04       Impact factor: 3.316

Review 9.  Computed tomography colonography in 2014: an update on technique and indications.

Authors:  Andrea Laghi
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Antimicrobial prophylaxis in patients with colorectal lesions undergoing endoscopic resection.

Authors:  Qi-Sheng Zhang; Bing Han; Jian-Hua Xu; Peng Gao; Yu-Cui Shen
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.